CL

In the past six months, Colgate-Palmolive Co. (CL) stock has experienced modest, range-bound trading, declining approximately 5% from the low-$88 range to the mid-$84 range as of early October 2026. Key events include Q1 2026 earnings reporting net sales up 8.4% and organic sales up 2.9%, with Base Business EPS up 7%. Q2 2026 earnings showed net sales increasing 4.9% year-over-year to $5.36 billion and organic sales up 2.4%, with Base Business diluted EPS rising 8% and gross profit margin increasing by 140 basis points. The company declared a regular quarterly cash dividend of $0.53 per common share, payable on November 13, 2026, continuing its uninterrupted dividend payments since 1895. Several analysts, including Wells Fargo & Company and Piper Sandler, adjusted their price targets for CL downwards. Insider activity included approximately $16.1 million of stock sales over the past 90 days, largely by the CEO to cover tax obligations.